Showing results (41-50 of 69) with videos related to
Sort By:
Pageof 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
A phase I study of sequential irinotecan and 5-fluorouracil/leucovorinR M Goldberg, S H Kaufmann, P Atherton, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Randomized comparison of four tools measuring overall quality of life in patients with advanced cancerJ A Sloan, C L Loprinzi, S A Kuross, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2001
Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566C Erlichman, A A Adjei, S R Alberts, et al.American Journal of Clinical Oncology|February 20, 1999
Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancerR F Marschke, J P Grill, J A Sloan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancerC L Loprinzi, S Abu-Ghazaleh, J A Sloan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumorsA A Adjei, C Erlichman, J A Sloan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivorsC L Loprinzi, T M Pisansky, R Fonseca, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group TrialS K Quella, C L Loprinzi, D L Barton, et al.Lung Cancer (Amsterdam, Netherlands)|March 16, 2000
A randomized phase II trial of two schedules of topotecan for the treatment of advanced stage non-small cell lung cancerJ J Weitz, R F Marschke, J A Sloan, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 10, 2015
Endpoint comparison for bone mineral density measurements in North Central Cancer Treatment Group cancer clinical trials N02C1 and N03CC (Alliance)A C Dueck, J Singh, P Atherton, et al.Pageof 7